Due to the loosening of policies, the traditional Chinese medicine injection market is expected to take a turn for the better in 2010. Among them, Xi'an Century Shengkang Pharmaceutical's Shenkang Injection is accelerating its production expansion. Loosening of policies has given rise to an industry turning point. According to a pharmaceutical industry analyst from CIC Securities, after the rectification in 2006, the traditional Chinese medicine injection industry has entered a process of healthy development. In December 2009, the Drug Evaluation Center of the State Food and Drug Administration began to re-evaluate new varieties of traditional Chinese medicine injections, which marked the official thawing of the long-suspended approval of traditional Chinese medicine injections. The industry is approaching a major turning point, and the industry is expected to usher in accelerated growth. Medical experts believe that Chinese people generally believe that "Chinese medicines have less toxic and side effects than Western medicines." Traditional Chinese medicine injections, because they directly enter the blood and have rapid effects, can overcome the shortcomings of "slowness" of traditional Chinese medicine. Therefore, Chinese medicine injections have always been favored by patients. According to statistics, 400 million people use traditional Chinese medicine injections in my country every year. A medical expert told reporters that at present, my country's traditional Chinese medicine injections have covered more than 1,400 hospitals in 21 provinces and cities, with annual sales of approximately 20 billion yuan. They were included in the 2009 national medical insurance catalog and the basic version of the essential medicine catalog. There are 46 varieties and 8 varieties respectively. Precisely because traditional Chinese medicine injections have unique advantages, the future market growth is unlimited. According to analysis by people in the pharmaceutical industry, in the market segment, renal vascular medication is the advantageous area of ??traditional Chinese medicine, among which traditional Chinese medicine injections occupy a dominant position. According to data from the Institute of Medical Economics, traditional Chinese medicine injections in the field of renal function rehabilitation achieved a relatively high growth rate in 2008. This year, among the traditional Chinese medicine renal function recovery injection companies, in addition to traditional Chinese medicine giants such as Tasly, Yibai Pharmaceutical, and Sanjiu Medicine, the ones produced by Xi'an Century Shengkang Pharmaceutical Co., Ltd. have undergone strict drug quality appraisal and are approved by The new Shenkang injection, the only SFDA-approved treatment for renal failure, is also worth looking forward to. Xi'an Century Shengkang: Exclusive medical insurance product - Shenkang Injection has broad space. Xi'an Century Shengkang Pharmaceutical has accelerated the pace of production and laid out the Shenkang Injection market. When asked about Shenkang Injection, which is newly launched this year, news from Century Shengkang Pharmaceutical Company said that in October 2009, Xi'an Century Shengkang (formerly Xi'an Jiahui) Pharmaceutical Co., Ltd. completed its corporate restructuring and obtained national reorganization. Certification. It is reported that Shenkang Injection produced by Xi'an Century Shengkang Pharmaceutical Co., Ltd. is a national second-class new drug of traditional Chinese medicine and is mainly used to treat chronic renal failure. It is an exclusive medical insurance product in the field of kidney disease and has won six national invention patents and five international and domestic awards. Its application can effectively treat or control the progression of patients with chronic renal failure, prevent or delay patients from entering dialysis, effectively improve the quality of life of patients, and greatly reduce treatment costs. Its clinical application has no toxic side effects and obvious adverse reactions. It is It is an effective drug for the treatment of chronic renal failure and the only traditional Chinese medicine injection for the treatment of chronic renal failure. Relevant people from Century Shengkang Company said that the newly launched Shenkang Injection uses authentic medicinal materials, optimized processes, strict control, advanced management, stable quality, safety and reliability. From the procurement of raw materials and auxiliary materials to the delivery of final products, fingerprints control the quality throughout the entire process and strictly control quality. The key inspection items of each batch of products must pass the dual-track inspection by the Shaanxi Provincial Institute for Drug Control and the Fourth Military Medical University before they can be put on the market. Currently, the company is working closely with Tsinghua University and plans to use infrared spectroscopy technology to control the quality of the entire production process of Shenkang Injection, aiming to more directly and quickly control the quality of the entire pharmaceutical production process. This project combines infrared spectroscopy with high-efficiency liquid The combination of phase chromatography and phase chromatography can realize the complementary advantages of the two and establish a new comprehensive quality control method of traditional Chinese medicine. The establishment of this method is of great significance to the entire traditional Chinese medicine industry and related fields. In fact, Xi'an Century Shengkang Pharmaceutical Co., Ltd.'s Shenkang injection sales have soared in 2010. In the first half of this year, the brand-new Shenkang Injection continued to sell well once it was launched, with half-year sales reaching 165 million. With the approval of the company's new products in the future and the entry of Shenkang Injection into the national medical insurance catalog, it is expected that it will maintain a rapid growth rate from 2010 to 2011. The market research report of Century Shengkang Company believes that from the perspective of the products that are about to be launched: In the next few years, Xi'an Century Shengkang Pharmaceutical's upcoming products will still be dominated by exclusive products in the field of kidney disease, and will expand market share around the field of kidney disease to do kidney disease. Aiming to become the first brand in the field, we will comprehensively develop the market.
Industry experts believe that Xi'an Century Shengkang Pharmaceutical Co., Ltd., which underwent asset restructuring in 2010, is very likely to become the leader of traditional Chinese medicine injections in the field of kidney disease by virtue of the product advantages of Shenkang Injection and the company's modern management.
Please adopt